Clinical tests begin on medication to correct Fragile X defect
Monday, November 2, 2009 - 13:49
in Health & Medicine
NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile
Read the whole article on Science Blog
More from Science Blog
Related
- Clinical tests begin on medication to correct Fragile X defectMon, 2 Nov 2009, 12:44:07 EST
- UCR researchers propose minocycline as a promising drug for patients with Fragile X syndromeFri, 3 Oct 2008, 11:42:43 EDT
- Promising new drug being evaluated as possible treatment option for fragile X syndromeWed, 7 Jan 2009, 9:51:28 EST
- Melatonin is an effective treatment for sleep problems in children with autismWed, 15 Apr 2009, 0:42:58 EDT
- NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidatesWed, 22 Jul 2009, 13:46:33 EDT